F773 in Delaware. Pick another state for the same tag.
Against expectation — 2025
Delaware cites F773 more often than its own record predicts
Versus expected share11.37×
11.37 times the share F773 takes of citations nationally.
Share of Delaware citations1.49%
Of every deficiency written in Delaware in 2025, this is the portion that was F773.
Delaware1.49%
National0.13%
Share of all citations that were F773.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Delaware surveyors wrote
F773 findings written in Delaware, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedDecember 16, 2025
Based on record review and interview it was determined that for one (R20) out of three residents reviewed for transmission-based precautions the facility failed to ensure that a physician was notified promptly of laboratory results. Findings include:Review of R20's clinical record revealed: 12/8/25 - A physician's order was written for R20 to have a urinalysis culture and sensitivity test completed. 12/11/25 - R20's urinalysis culture and sensitivity was collected by the contracted laboratory. 12/13/25 - The results of R20's urinalysis culture and sensitivity were relayed to the facility by phone to E24 (LPN). R20's progress notes lacked evidence that E24 relayed the results to R20's physician or nurse practitioner. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction